Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 4, 2024
Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational studyKenneth R Chapman, Kathryn Cogger, Erin Arthurs, et al.Canadian Journal of Diabetes|May 30, 2025
Hypertension Treatment and Control in Canadians With DiabetesSachin V Pasricha, Lisa Dubrofsky, Bailey Goldman, et al.Digestive Diseases and Sciences|October 5, 2023
Perianal Fistulas Are Associated with Persistently Higher Direct Health Care Costs in Crohn's Disease: A Population-Based StudyJeffrey D McCurdy, Johnny H Chen, Shane Golden, et al.Rheumatology and Therapy|August 31, 2022
Usage and Adherence of Seven Advanced Therapies with Differing Mechanisms of Action for Inflammatory Arthritis in CanadaFrancois Nantel, Juejing Ling, Meagan Rachich, et al.Canadian Journal of Diabetes|March 23, 2023
Impact of the COVID-19 Pandemic on Antihyperglycemic Prescriptions for Adults With Type 2 Diabetes in Canada: A Cross-sectional StudyAlice Y Y Cheng, Ronald Goldenberg, Iris Krawchenko, et al.Vaccines|April 28, 2023
Burden of Acute-Care Hospitalization for Community-Acquired Pneumonia in Canadian Adults Aged 50 Years or Older: Focusing on Most Responsible Diagnosis Tells Only Part of the StoryAna Gabriela Grajales Beltrán, Derek Lytle, Jelena Vojicic, et al.Canadian Journal of Diabetes|February 24, 2023
Impact of the COVID-19 Pandemic on Adults With Type 2 Diabetes Care and Clinical Parameters in a Primary Care Setting in Ontario, Canada: A Cross-sectional StudyAlice Y Y Cheng, Stewart Harris, Iris Krawchenko, et al.Clinical Trials (London, England)|April 19, 2021
Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trialsMatthew C Cheung, Kelvin Kw Chan, Shane Golden, et al.Diabetes, Obesity & Metabolism|December 15, 2020
A retrospective observational population-based study to assess the prevalence and burden of illness of type 2 diabetes with an estimated glomerular filtration rate < 90 mL/min/1.73 m<sup>2</sup> in Ontario, CanadaWally Rapattoni, David Zante, Marko Tomas, et al.Pageof 2